{"url_path":"/sec/rlyb/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1739410/0001628280-26-034580-index.html","accession_number":"0001628280-26-034580","cik":"0001739410","ticker":"RLYB","issuer_name":"Rallybio Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1739410/0001628280-26-034580-index.html","primary_entity_key":"0001739410","primary_entity_name":"Rallybio Corp"},"word_count":49,"has_tables":true,"body_markdown":"Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.\n\n(a)\n\nExcept as disclosed in our previously filed current reports on Form 8-K, the Company has not issued equity securities of the Company on an unregistered basis during the quarter ended March 31, 2026.\n\n79\n\n[Table of Contents](#i15af2461236043f1aa58ea5a42666f82_7)"}